Cost Analysis of Hospital Treatment for Peritoneal Dialysis-Associated Peritonitis

Background: Increasing healthcare spending is a significant issue, with the aging population contributing to a rise in patients needing renal replacement therapy. The cost of peritoneal dialysis (PD) is substantial, particularly in upper-middle-income countries like Serbia. We aimed to identify the direct costs and influencing factors of treating peritoneal dialysis-associated peritonitis (PD associate peritonitis) in Serbia.
Methods: A retrospective observational study was conducted on consecutive patients admitted due to PD-associated peritonitis in five tertiary care hospitals across Serbia in 2019-2022. The primary outcome was total cost of hospitalization. Potential predictors were determined using generalized linear model with a gamma probability distribution and a log link function.
Results: The study included 122 patients. The average total cost per patient was 1131.90±1538.67 USD, with the cost of hospitalization (348.17 ± 361.52 USD) and antibiotics (294.94±465.88 USD) being the most significant. The length of hospitalization (P<0.001) and treatment outcome (P<0.001) were found to be significant predictors of the total cost.
Conclusion: The costs of treating PD associate peritonitis in Serbia are substantial, with each additional day of hospitalization significantly increasing the cost. The importance of patient and doctor education about infection prevention is underscored by the health consequences and the lengthy, expensive treatment when an infection occurs.

1. Watt T, Charlesworth A, Gershlick B (2019). Health and care spending and its value, past, present and future. Future Healthc J, 6(2):99–105.
2. Liyanage T, Ninomiya T, Jha V, et al (2015). Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet, 385(9981):1975–82.
3. Bello AK, Okpechi IG, Levin A, et al (2024). An update on the global dispari-ties in kidney disease burden and care across world countries and regions. Lan-cet Glob Health, 12(3):e382–95.
4. Jo C (2014). Cost-of-illness studies: con-cepts, scopes, and methods. Clin Mol Hepatol, 20(4):327-37.
5. Xie F, Thumboo J, Fong KY, et al (2008). A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore. Value Health, 11 Suppl 1:S84-90.
6. Sachdeva B, Zulfiqar H, Aeddula NR. Peri-toneal Dialysis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publish-ing; 2025 Jan.
7. Mehrotra R, Devuyst O, Davies SJ, Johnson DW (2016). The Current State of Perito-neal Dialysis. J Am Soc Nephrol, 27(11):3238–52.
8. Redpath Mahon AC, Richardson T, Neu AM, Warady BA (2019). Factors associat-ed with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States. Pediatr Nephrol, 34(6):1049–55.
9. National Bank of Serbia. Average exchange rates [Internet]. 2024 [cited 2024 Mar 30]. Available from: https://nbs.rs/en/indeks
10. Faul F, Erdfelder E, Buchner A LA (2009). Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods, 41(4):1149–60.
11. Madsen HO, Hanehøj M, Das AR, et al (2009). Costing of severe pneumonia in hospitalized infants and children aged 2–36 months, at a secondary and ter-tiary level hospital of a not‐for‐profit organization. Trop Med Int Health, 14(10):1315–22.
12. de la Espada Piña V, Ganga PLQ, Junquero JMG, et al (2021). Two decades of analy-sis of peritonitis in peritoneal dialysis in Andalusia: Epidemiological, clinical, microbiological and progression as-pects. Nefrologia (Engl Ed), 41(4):417–25.
13. Makhija DU, Walton SM, Mora JP, Sana-bria RM (2017). Economic Impact of a Peritoneal Dialysis Continuous Quality Improvement Program in Colombia. Perit Dial Int, 37(2):165–9.
14. Vogel SL, Singh T, Astor BC, Waheed S (2020). Gender differences in peritoneal dialysis initiation in the US end-stage renal disease population. Perit Dial Int, 40(1):57–61.
15. Kitterer D, Segerer S, Braun N, et al (2017). Gender-Specific Differences in Perito-neal Dialysis. Kidney Blood Press Res, 42(2):276-283.
16. Kotsanas D, Polkinghorne KR, Korman TM, et al (2007). Risk factors for perito-neal dialysis‐related peritonitis: Can we reduce the incidence and improve pa-tient selection? Nephrology (Carlton), 12(3):239–45.
17. Webster AC, Nagler E V, Morton RL, Mas-son P (2017). Chronic Kidney Disease. Lancet, 389(10075):1238–52.
18. Diamantis P Kofteridis 1, Antonios Vala-chis, Kostas Perakis, et al. (2010). Perito-neal dialysis-associated peritonitis: clini-cal features and predictors of outcome. Int J Infect Dis, 14(6):e489-93.
19. Redpath Mahon AC, Richardson T, Neu AM, et al (2019). Factors associated with high-cost hospitalization for peritonitis in children receiving chronic peritoneal dialysis in the United States. Pediatr Nephrol, 34(6):1049–55.
20. Versporten A, Bolokhovets G, Ghazaryan L, et al (2014). Antibiotic use in Eastern Europe: a cross-national database study in coordination with the WHO Regional Office for Europe. Lancet Infect Dis, 14(5):381–7.
21. Salzer WL. Peritoneal dialysis-related peri-tonitis: challenges and solutions (2018). Int J Nephrol Renovasc Dis, 11:173–86.
22. Szeto CC, Li PKT (2019). Peritoneal Dialy-sis–Associated Peritonitis. Clin J Am Soc Nephrol, 14(7):1100–1105.
23. Li PKT, Chow KM, Cho Y, et al (2022). ISPD peritonitis guideline recommenda-tions: 2022 update on prevention and treatment. Perit Dial Int, 42(2):110–53.
24. Pejcic A V, Jakovljevic M (2017). Pharma-ceutical expenditure dynamics in the Balkan countries. J Med Econ, 20(10):1013–7.
25. CEIC Data. Serbia Monthly Earnings, 2000 – 2024 [Internet]. [cited 2024 Apr 1]. Available from: https://www.ceicdata.com/en/indicator/serbia/monthly-earnings

Files	XML PDF (491KB)
Issue	Vol 54 No 6 (2025)
Section	Original Article(s)
Keywords
Peritoneal dialysis Peritonitis Costs

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

How to Cite

Stojadinovic M, Zivkovic Zaric R, Petrovic D, Kezic A, Radovic M, Jovicic Pavlovic S, Mrdja I, Hadzi Tanovic L, Knezevic V, Pilcevic D, Jemcov T, Karapandzic M, Jankovic S. Cost Analysis of Hospital Treatment for Peritoneal Dialysis-Associated Peritonitis. Iran J Public Health. 2025;54(6):1225-1232.

Vancouver

Download Citation